Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Infosys Limited (INFY) vs Tilray Brands Inc (TLRY) Price & Performance

Infosys LimitedTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Infosys Limited vs Tilray Brands Inc — how do they compare? Infosys Limited trades at $11.26 (market cap $46.65B), while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: Infosys Limited is far larger — about 89× Tilray Brands Inc's market cap, and Infosys Limited pays a 4.63% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

INFYTLRY
Market Cap
$46.65B$524.07M
Sector
TechnologyHealth
52-Week High
$20.22$21.00
52-Week Low
$10.49$4.23
Enterprise Value
$43.87B$621.22M
Dividend Yield
4.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Infosys Limited

INFY trades at $11.31, down 1.57% on the day, with a bullish technical signal despite bearish moving averages. The stock shows strong profitability with a 16.44% net income margin and 31.57% ROE, supported by recent earnings beats. Recent news highlights AI collaborations with firms like Sentara and GlobalFoundries, positioning the company for growth in enterprise AI services.

The outlook is cautiously optimistic with a consensus price target of $12.28, implying 8.6% upside. Risks include competitive pressures in IT services and potential volatility from sector-wide demand concerns, as seen with Accenture's recent outlook. Analyst sentiment is mixed, with 37.5% buy ratings but a majority hold stance, reflecting balanced near-term expectations.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.

The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Infosys Limited

Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.

Read more on INFY

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY